THROMBOMODULIN, A PROTECTIVE MARKER AGAINST CORONARY ARTERY DISEASE
1MUHAMMAD AKBAR MUGHAL, 2ABDUL SHAKOOR MEMON, 3BASHIR HANIF, 4NARGIS ANJUM
ABSTRACT
Objectives: (1)
To compare the serum thrombomodulin levels between apparently healthy
subjects and patients with myocardial infarction and unstable angina
& (2) To assess, whether it may be identified as a protective marker
for determining the incidence of coronary artery disease
Material and Methods: The controls and patients
were taken by convenient sampling. A total of 32 control (healthy)
subjects were compared with 32 consecutive patients with history
of myocardial infarction, (M.I.) and 32consecutive patients with
history of unstable angina (U.A.) respectively. The diagnosis of
myocardial infarction (M.I.) and unstable angina was made on the
basis of history, E.C.G. & Trop. I levels. Serum thrombomodulin
and serum lipid profile of each subject were determined by ELISA
Kit methods. One way analysis of variance (ANOVA) was conducted
for comparison of serum thrombomodulin level among healthy, Myocardial
infarction (M.I.) & unstable angina (U.A.) patients.
Results: Serum Thrombomodulin levels were significantly
higher in controls when compared to patients of myocardial infarction
and unstable angina. Serum L.D.L. cholesterol and total cholesterol
levels were significantly higher in diseased group in comparison
with control.
Conclusion: Inour study healthy population had
increased Thrombomodulin levels as compared to patients of coronary
artery disease (C.A.D.)
Key words: Thrombomodulin (TM), Myocardial Infarction,
Unstable angina.
|